Perspective Therapeutics, Inc. (CATX)
NYSEAMERICAN: CATX · Real-Time Price · USD
3.090
+0.700 (29.29%)
At close: Jun 3, 2025, 4:00 PM
3.150
+0.060 (1.94%)
After-hours: Jun 3, 2025, 8:00 PM EDT

Perspective Therapeutics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024 FY 2023 FY 2022 FY 2022 FY 2021 2016 - 2020
Period Ending
Jun '25 Dec '24 Dec '23 Dec '22 Jun '22 Jun '21 2016 - 2020
Market Capitalization
2292161133544113
Upgrade
Market Cap Growth
-77.42%91.16%221.19%-19.99%-61.12%200.36%
Upgrade
Enterprise Value
21-4898-19-1449
Upgrade
Last Close Price
3.093.194.022.473.097.98
Upgrade
PS Ratio
147.33148.2878.656.49-11.23
Upgrade
PB Ratio
0.800.741.500.640.721.68
Upgrade
P/TBV Ratio
0.980.90147.820.640.721.68
Upgrade
EV/Sales Ratio
14.23-68.42--4.86
Upgrade
Debt / Equity Ratio
0.010.010.03-0.010.01
Upgrade
Asset Turnover
0.010.010.02--0.25
Upgrade
Inventory Turnover
-----6.07
Upgrade
Quick Ratio
16.7012.530.6714.4725.3836.58
Upgrade
Current Ratio
17.0212.681.0817.0726.1837.37
Upgrade
Return on Equity (ROE)
-32.92%-42.82%-57.70%--9.79%-9.26%
Upgrade
Return on Assets (ROA)
-15.56%-19.02%-32.81%--5.95%-5.43%
Upgrade
Return on Capital (ROIC)
-18.14%-22.42%-38.66%--6.17%-5.73%
Upgrade
Earnings Yield
-37.22%-36.77%-41.23%-30.64%-16.57%-3.00%
Upgrade
FCF Yield
-45.33%-33.72%-33.68%-30.42%-18.17%-2.85%
Upgrade
Buyback Yield / Dilution
-109.82%-140.72%-88.38%-0.06%-36.73%-53.61%
Upgrade
Updated May 12, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q